REFERENCES
[1] George EM, Herzog TJ, Neugut AI, et al. Carcinosarcoma of the ovary: natural history, patterns of treatment, and outcome. Gynecol Oncol. 2013;131(1):42-5.
[2]. Harris MA, Delap LM, Sengupta PS, et al. Carcinosarcoma of the ovary. Br J Cancer 2003;88(5):654-7.
[3] Prachi S, Pankaj P, Yelikar BR. Bilateral ovarian carinosarcoma-a rare entity. Int J Med Res Health Sci. 2015;4(1):242-4.
[4] Brown E, Stewart M, Rye T, et al. Carcinosarcoma of the ovary: 19 years of prospective data from a single center. Cancer 2004; 100:2148‑53.
[5] Lamb MR, Gertsen E, Middlemas E. Carcinosarcoma of the ovary: Case report and literature review. Tenn Med 2012; 105:41‑2.
[6] Petru E, Haas J, Beganovic S, et al. Carcinosarcoma (Malignant Mixed Muellerian Tumor) of the Ovary-A Single Institution Experience of 25 years. Int J Gynecol Clin Pract 2015,2:107.
[7] Wei LH, Huang C Y, Cheng SP, et al. Carcinosarcoma of ovary associated with previous radiotherapy. Int J Gynecol Cancer 2001; 11:81‑4.
[8] Kunkel J, Peng Y, Tao Y, et al. Presence of a sarcomatous component outside the ovary is an adverse prognostic factor for primary ovarian malignant mixed mesodermal/mullerian tumors: a clinicopathologic study of 47 cases. Am J Surg Pathol 2012; 36: 831-7.
[9] Leiser AL, Chi DS, Ishill NM, et al. Carcinosarcoma of the ovary treated with platinum and taxane: the memorial SloanKettering Cancer Center experience. Gynecol Oncol 2007;105: 657-61.
[10] Rauh-Hain JA, Growdon WB, Rodriguez N, et al. Carcinosarcoma of the ovary: a case-control study. Gynecol Oncol 2011;121: 477-81.